Clinical development of dopexamine hydrochloride (dopacard) and an overview of its hemodynamic effects

Publisher Website

1 August 1988

journal article
clinical trial
Published by Elsevier in The American Journal of Cardiology

Vol. 62 (5) , 41C-45C
https://doi.org/10.1016/s0002-9149(88)80066-3

Abstract

No abstract available

Keywords

This publication has 3 references indexed in Scilit:

Human renovascular effects of dopexamine hydrochloride: A novel agonist of peripheral dopamine and beta2-adreno-receptors
European Journal of Clinical Pharmacology, 1987
Acute haemodynamic and metabolic effects of dopexamine, a new dopaminergic receptor agonist, in patients with chronic heart failure.
Heart, 1985
Dopexamine: a novel agonist at peripheral dopamine receptors and β₂‐adrenoceptors
British Journal of Pharmacology, 1985